Theranos, once valued at $9 billion, promised to upend blood testing with a device called the Edison that could run hundreds of tests from a single finger-prick. Instead, the firm collapsed in September 2018 after it emerged that the tech never worked as claimed. Founder Elizabeth Holmes was found guilty of defrauding backers in January 2022 and began serving an 11.25-year prison sentence in May 2023. Her co-conspirator and former COO, Ramesh 'Sunny' Balwani, was found guilty on 12 counts of fraud in July 2022 and sentenced to nearly 13 years.
The scandal became the defining cautionary tale of Silicon Valley hype. Not because Theranos was a startup that failed, but because it was a fraud that succeeded for more than a decade. The venture attracted backers including Rupert Murdoch, the Walton family, and Betsy DeVos, and assembled a board that included former Secretaries of State Henry Kissinger and George Shultz. Those names helped deflect scrutiny until investigative reporting by The Wall Street Journal's John Carreyrou exposed the deception in October 2015.
The Promise of the Edison Device
Elizabeth Holmes founded Theranos in 2003, dropping out of Stanford University to pursue low-cost, accessible blood testing. The flagship product, the Edison, was supposed to run a comprehensive diagnostic panel from a few drops of blood drawn from a finger prick. Traditional draws require vials of blood and send samples to centralized laboratories. Theranos claimed its system would make testing faster, cheaper, and less invasive.
By 2014, the enterprise was valued at $9 billion. Holmes was celebrated as the next Steve Jobs, and Walgreens signed on to offer tests in its pharmacies. The problem was that the Edison never worked. Internal documents later showed that Theranos ran the vast majority of its tests on conventional commercial analyzers from Siemens, not on its own hardware. The firm hid this fact from backers, partners, and regulators.
The Board That Shielded the Fraud
A roster built for credibility, not expertise
Theranos's board was one of the most distinguished in corporate history. It was also one of the least qualified to oversee a medical diagnostics business. The directors included Henry Kissinger, George Shultz, former U.S. Senator Sam Nunn, former Secretary of Defense William Perry, and retired Marine General James Mattis. None had deep expertise in clinical diagnostics or laboratory medicine. Their role was to lend credibility and deflect questions.
How prestige silenced doubt
When reporters or regulators asked tough questions, Theranos pointed to the board as proof of legitimacy. The strategy worked for years. George Shultz's grandson, Tyler Shultz, worked at the firm and later became a whistleblower, but his grandfather initially dismissed his concerns. The board's stature made it difficult for employees and outsiders to raise alarms without being dismissed as troublemakers.
John Carreyrou and the Wall Street Journal Exposé
A reporter connects the dots
The unraveling began in October 2015, when The Wall Street Journal published an investigation by John Carreyrou. Carreyrou had spent months interviewing former employees, reviewing internal documents, and speaking with patients who had received questionable results. His reporting revealed that the Edison was inaccurate and unreliable, and that the operation was using conventional lab equipment for the vast majority of its tests.
Regulators move in
Carreyrou's articles prompted immediate scrutiny. In May 2016, Theranos voided two years of Edison blood-test results, acknowledging the data could not be trusted. The Centers for Medicare & Medicaid Services banned Elizabeth Holmes from owning or operating a clinical laboratory for at least two years in July 2016. The Food and Drug Administration also began investigating. The Walgreens partnership collapsed, and Theranos laid off 41% of its workforce in January 2017.
How Theranos Concealed the Truth
The demo that fooled everyone
Theranos employed a range of tactics to hide the failures of its system from backers, partners, and patients. The firm built a facade of innovation by demonstrating the Edison to visitors using a dummy sample or a device programmed to produce a specific result. When Walgreens requested validation data, Theranos provided cherry-picked results from a small number of tests that happened to work. Employees were pressured to remain silent through non-disclosure agreements and threats of litigation.
The secret Siemens machines
Perhaps the most damaging deception was the use of conventional lab equipment. Theranos told financiers that its proprietary system was running tests, when in fact the business was buying Siemens analyzers and running them behind a wall of secrecy. Patients who received results were often given inaccurate data. In one case, a patient was told she had had a miscarriage when she was still pregnant. The focus on secrecy and growth over accuracy and safety was a direct consequence of the culture set by Holmes and Balwani.
The Criminal Trials and Convictions
The prosecution's case
Elizabeth Holmes was indicted on federal fraud charges in June 2018, three months before Theranos dissolved. Her trial began in September 2021. The prosecution argued that Holmes knowingly misled backers about the Edison's capabilities and personally approved marketing materials containing false claims. The defense argued that Holmes was a young entrepreneur who believed in her product and was let down by those around her.
Two guilty verdicts
The jury found Holmes guilty on four counts of defrauding investors in January 2022. She was sentenced to 11.25 years and began serving her sentence in May 2023. Ramesh 'Sunny' Balwani, who had been president and COO, was tried separately and found guilty on 12 counts of fraud in July 2022. He received nearly 13 years. The verdicts sent a signal that Silicon Valley's culture of 'fake it till you make it' has legal limits, especially when backers and patients are harmed.
What the Theranos Scandal Changed
The scandal did not end with the dissolution. It prompted a reassessment of how venture capital and corporate boards evaluate startups, particularly in regulated industries like healthcare. Funders who had relied on the prestigious board and charismatic founder began demanding more rigorous due diligence. The case also led to changes in how the FDA and CMS oversee laboratory-developed tests, though those reforms remain incomplete as of May 2023.
For the backers who lost money, including Rupert Murdoch, the Walton family, and Betsy DeVos, the lesson was expensive. For Walgreens, which had invested heavily in the partnership, the damage was reputational and financial. The broader startup ecosystem absorbed a cautionary tale about the dangers of hype. Theranos showed that a compelling narrative, a famous board, and a charismatic founder are not substitutes for working tech. The rise and fall remains the standard reference point for what can go wrong when ambition outruns reality in Silicon Valley.
Key Facts: Theranos Timeline
- Founded: 2003 by Elizabeth Holmes
- Peak valuation: $9 billion
- WSJ exposé published: October 2015
- CMS ban on Holmes: July 2016
- Company dissolved: September 2018
- Holmes conviction: January 2022 (4 counts of fraud)
- Holmes prison sentence began: May 2023 (11.25 years)
- Balwani conviction: July 2022 (12 counts of fraud)
Key Individuals and Their Roles
| Name | Role at Theranos | Outcome |
|---|---|---|
| Elizabeth Holmes | Founder and CEO | Convicted of fraud, sentenced to 11.25 years |
| Ramesh 'Sunny' Balwani | President and COO | Convicted of 12 fraud counts, sentenced to nearly 13 years |
| Henry Kissinger | Board member | No charges; role as credibility shield |
| George Shultz | Board member | No charges; his grandson became a whistleblower |
| John Carreyrou | Wall Street Journal reporter | Exposed the fraud in October 2015 |
Frequently Asked Questions
What was the Edison device?
Theranos claimed the Edison could run hundreds of diagnostic blood tests from a single finger-prick sample. In reality, the device never worked reliably, and the company used conventional Siemens analyzers for most tests.
Who were the main investors in Theranos?
Key backers included Rupert Murdoch, the Walton family, and Betsy DeVos. The firm was valued at $9 billion at its peak.
Did Elizabeth Holmes go to prison?
Yes. She was found guilty of defrauding investors in January 2022 and began serving an 11.25-year sentence in May 2023.
How did the Wall Street Journal uncover the fraud?
Reporter John Carreyrou spent months interviewing former employees and reviewing internal documents. His first exposé was published in October 2015.
What happened to Walgreens after the scandal?
Walgreens ended its partnership with Theranos after the WSJ exposé and later faced lawsuits from patients who had received inaccurate test results.
